Six1 overexpression in mammary cells induces genomic instability and is sufficient for malignant transformation

被引:83
作者
Coletta, Ricardo D. [1 ]
Christensen, Kimberly L. [5 ]
Micalizzi, Douglas S. [5 ]
Jedlicka, Paul [2 ]
Varella-Garcia, Marilefla [3 ]
Ford, Heide L. [1 ,4 ,5 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Obstet & Gynecol, Aurora, CO 80045 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Pathol, Aurora, CO 80045 USA
[3] Univ Colorado, Hlth Sci Ctr, Dept Med Oncol, Aurora, CO 80045 USA
[4] Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Aurora, CO 80045 USA
[5] Univ Colorado, Hlth Sci Ctr, Program Mol Biol, Aurora, CO 80045 USA
关键词
D O I
10.1158/0008-5472.CAN-07-3141
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Homeoproteins are transcription factors that act as master regulators of development and are frequently dysregulated in cancers. During embryogenesis, the Six1 homeoprotein is essential for the expansion of precursor cell populations that give rise to muscle and kidney, among other organs. Six1 overexpression is observed in numerous cancers, resulting in increased proliferation, survival, and metastasis. Here, we investigate whether Six1 can play a causal role in mammary tumor initiation. We show that Six1 overexpression in MCF12A mammary epithelial cells promotes multiple properties associated with malignant transformation, including increased proliferation, genomic instability, and anchorage-independent growth. We further show that this transformation is dependent on up-regulation of its transcriptional target, cyclin A1, which is normally expressed in the embryonic mammary gland but dramatically reduced in the adult gland. Sixl-transformed MCF12A cells are tumorigemic in nude mice, forming aggressive tumors that are locally invasive and exhibit peritumoral lymphovascular invasion. In human breast carcinomas, expression of Six1 and cyclin A1 mRNA correlate strongly with each other (P < 0.0001), and expression of Six1 and cyclin A1 each correlate with Ki67, a marker of proliferation (P < 0.0001 and P = 0.014, respectively). Together, our data indicate that Six1 overexpression is sufficient for malignant transformation of immortalized, nontumorigenic mammary epithelial cells, and suggest that the mechanism of this transformation involves inappropriate reexpression of cyclin A1 in the adult mammary gland.
引用
收藏
页码:2204 / 2213
页数:10
相关论文
共 49 条
[1]   Homeobox genes and cancer: New OCTaves for an old tune [J].
Abate-Shen, C .
CANCER CELL, 2003, 4 (05) :329-330
[2]   Deregulated homeobox gene expression in cancer: Cause or consequence? [J].
Abate-Shen, C .
NATURE REVIEWS CANCER, 2002, 2 (10) :777-785
[3]   Six1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival [J].
Behbakht, Kian ;
Qamar, Lubna ;
Aldridge, Carrie S. ;
Coletta, Ricardo D. ;
Davidson, Susan A. ;
Thorburn, Andrew ;
Ford, Heide L. .
CANCER RESEARCH, 2007, 67 (07) :3036-3042
[4]   Transformation of human and murine fibroblasts without viral oncoproteins [J].
Boehm, JS ;
Hession, MT ;
Bulmer, SE ;
Hahn, WC .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (15) :6464-6474
[5]   Cell cycle regulation of the human Six1 homeoprotein is mediated by APCCdh1 [J].
Christensen, K. L. ;
Brennan, J. D. G. ;
Aldridge, C. S. ;
Ford, H. L. .
ONCOGENE, 2007, 26 (23) :3406-3414
[6]   Basaloid squamous carcinoma of oral cavity: a histologic and immunohistochemical study [J].
Coletta, RD ;
Cotrim, P ;
Almeida, OP ;
Alves, VAF ;
Wakamatsu, A ;
Vargas, PA .
ORAL ONCOLOGY, 2002, 38 (07) :723-729
[7]   The Six1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A1 [J].
Coletta, RD ;
Christensen, K ;
Reichenberger, KJ ;
Lamb, J ;
Micomonaco, D ;
Huang, LL ;
Wolf, DM ;
Müller-Tidow, C ;
Golub, TR ;
Kawakami, K ;
Ford, HL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (17) :6478-6483
[8]  
FIRMEN RL, 2006, J VIROL, V80, P10325
[9]   Abrogation of the G2 cell cycle checkpoint associated with overexpression of HSIX1:: A possible mechanism of breast carcinogenesis [J].
Ford, HL ;
Kabingu, EN ;
Bump, EA ;
Mutter, GL ;
Pardee, AB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (21) :12608-12613
[10]   Oct-3/4 is a dose-dependent oncogenic fate determinant [J].
Gidekel, S ;
Pizov, G ;
Bergman, Y ;
Pikarsky, E .
CANCER CELL, 2003, 4 (05) :361-370